Fulcrum Therapeutics, Inc. (FULC) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$7.59
Day's range
$8.12

Fulcrum Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2026 6.56 M $50.32 M   0.00% 8.61%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 6.05 M $46.43 M   0.00% 7.94%
BLACKROCK, INC. 05/13/2026 5.39 M $41.35 M   26.43% 7.07%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 5.25 M $40.27 M   0.00% 6.89%
BRAIDWELL LP 05/15/2026 3.13 M $24.04 M   2.41% 4.11%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 3.05 M $23.39 M   -28.96% 4.00%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 2.69 M $20.65 M   100.00% 3.53%
SIREN, L.L.C. 05/14/2026 2.35 M $18.02 M   20.51% 3.08%
FIRST TURN MANAGEMENT, LLC 05/15/2026 2.26 M $17.30 M   19.20% 2.96%
ABRDN PLC 04/29/2026 2.21 M $16.97 M   76.39% 2.90%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 2.07 M $15.91 M   -13.48% 2.72%
GSK PLC 05/14/2026 1.79 M $13.70 M   0.00% 2.34%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 1.78 M $13.65 M   83.42% 2.34%
JONES HILL CAPITAL LP 05/14/2026 1.77 M $13.59 M   100.00% 2.32%
D. E. SHAW & CO., INC. 05/15/2026 1.62 M $12.45 M   -15.18% 2.13%
STATE STREET CORP 05/15/2026 1.55 M $11.89 M   54.16% 2.03%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.49 M $11.40 M   34.43% 1.95%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 1.33 M $10.19 M   100.00% 1.74%
CITADEL ADVISORS LLC 05/15/2026 1.29 M $9.91 M   7.08% 1.70%
ASSENAGON ASSET MANAGEMENT S.A. 04/20/2026 1.19 M $9.16 M   100.00% 1.57%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 1.13 M $8.66 M   7.53% 1.48%
VESTAL POINT CAPITAL, LP 05/15/2026 1.10 M $8.44 M   15.79% 1.44%
IKARIAN CAPITAL, LLC 05/15/2026 1.05 M $8.05 M   -23.72% 1.38%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 974.74 K $7.48 M   148.35% 1.28%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 736.68 K $5.65 M   26.50% 0.97%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 727.32 K $5.57 M   -1.28% 0.95%
VANGUARD PORTFOLIO MANAGEMENT LLC 05/08/2026 599.38 K $4.60 M   100.00% 0.79%
GOLDMAN SACHS GROUP INC 05/15/2026 571.91 K $4.39 M   76.58% 0.75%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 543.17 K $4.17 M   3,403.84% 0.71%
NORTHERN TRUST CORP 05/14/2026 472.99 K $3.63 M   -14.35% 0.62%
TREXQUANT INVESTMENT LP 05/15/2026 453.53 K $3.48 M   27.56% 0.60%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 426.87 K $3.27 M   9.76% 0.56%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 419.95 K $3.22 M   6.41% 0.55%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 400.00 K $3.07 M   -76.47% 0.52%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 400.00 K $3.07 M   100.00% 0.52%
JUMP FINANCIAL, LLC 05/14/2026 369.81 K $2.84 M   301.09% 0.49%
MILLENNIUM MANAGEMENT LLC 05/15/2026 356.47 K $2.73 M   554.90% 0.47%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 329.88 K $2.53 M   100.00% 0.43%
UBS GROUP AG 05/05/2026 315.19 K $2.42 M   206.10% 0.41%
JANE STREET GROUP, LLC 05/12/2026 310.42 K $2.38 M   -37.13% 0.41%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 303.99 K $2.33 M   -41.26% 0.40%
BESSEMER GROUP INC 05/06/2026 286.99 K $2.20 M   0.00% 0.38%
PANAGORA ASSET MANAGEMENT INC 05/14/2026 243.57 K $1.87 M   100.00% 0.32%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2026 205.00 K $1.57 M   100.00% 0.27%
SQUAREPOINT OPS LLC 05/15/2026 175.94 K $1.35 M   167.18% 0.23%
MORGAN STANLEY 05/15/2026 173.34 K $1.33 M   4.66% 0.23%
AMERICAN CENTURY COMPANIES INC 05/15/2026 156.24 K $1.20 M   -0.91% 0.21%
STATE OF WISCONSIN INVESTMENT BOARD 05/15/2026 154.44 K $1.18 M   78.54% 0.20%
Y-INTERCEPT (HONG KONG) LTD 04/27/2026 153.34 K $1.18 M   129.85% 0.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 150.00 K $1.15 M   6.76% 0.20%

Fulcrum Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 65 institutional investors and hedge funds held shares of Fulcrum Therapeutics Inc. The most heavily invested institutionals were:

BAILARD, INC.: 0

SIMPLEX TRADING, LLC: 0

Quantinno Capital Management LP: 0

BRAIDWELL LP: 0

Vestal Point Capital, LP: 0

Matisse Capital: 0

113.20% of Fulcrum Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 9.00 M shares in the last 24 months. This purchase volume represents approximately $71.49 M in transactions.